AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 8

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.05 % area, n=619. Read the 2025-Q2 state-of-the-index report →

619 records16 pagesmedian on this page 99.20 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020430KPVMKMMKM-2504-N4868PeptideMeter2025-Q299.725.44—Buyer-sourced0PASS
AX-2025-020402TirzepatideMKMMKM-2411-B3993Janoshik2025-Q298.084.70—Buyer-sourced0PASS
AX-2025-020208OxytocinERPERP-2503-A9615VendorInvestigate2025-Q299.115.36102.6Buyer-sourced0PASS
AX-2025-020060RetatrutideSWBSWB-2503-P7565Janoshik2025-Q298.544.52—Buyer-sourced1MARGINAL
AX-2025-018970SelankASYASY-{CAT}-1298Janoshik2025-Q299.439.07—Buyer-sourced1MARGINAL
AX-2025-018609N-Acetyl Semax AmideQYBQYB-2501-C5179Janoshik2025-Q299.936.0294.2Buyer-sourced0PASS
AX-2025-018575N-Acetyl Semax AmideQYBQYB-2411-G5028Medutest2025-Q299.549.73—Buyer-sourced0PASS
AX-2025-020852IpamorelinCPCCPC-2502-D1911PeptideMeter2025-Q298.744.8094.4Buyer-sourced1FAIL
AX-2025-020706MGFSGNSGN-2503-S9261Janoshik2025-Q299.483.35—Buyer-sourced1MARGINAL
AX-2025-020027IpamorelinSWBSWB-2501-Y7592Janoshik2025-Q299.474.80—Buyer-sourced1MARGINAL
AX-2025-019983TirzepatideHJHJ-2505-H6642PeptideMeter2025-Q298.595.2896.0Buyer-sourced0PASS
AX-2025-019211TirzepatideSinoPepSNP-2502-X4903PeptideMeter2025-Q298.426.41107.1Buyer-sourced0PASS
AX-2025-019075AOD-9604GSPGSP-2411-L2462Medutest2025-Q298.865.14—Buyer-sourced0PASS
AX-2025-019006RetatrutideASYASY-{CAT}-2342Medutest2025-Q299.561.3193.3Buyer-sourced0PASS
AX-2025-021234SermorelinPPGPPG-2412-K8216Janoshik2025-Q298.464.0092.0Buyer-sourced0PASS
AX-2025-020966TirzepatideWXTWXT-2411-F3188Janoshik2025-Q298.814.8493.8Supplier-supplied0PASS
AX-2025-020425KPVMKMMKM-2504-N4868Janoshik2025-Q299.685.77105.7Buyer-sourced0FAIL
AX-2025-020244IpamorelinGGPepsGGPE-2411-B1929Janoshik2025-Q299.054.9993.0Buyer-sourced1MARGINAL
AX-2025-019883MK-677 (Ibutamoren mesylate)HJHJ-2501-G5680Medutest2025-Q299.165.3591.3Buyer-sourced0FAIL
AX-2025-019105RetatrutideGSPGSP-2411-B2857PeptideMeter2025-Q297.717.5994.6Buyer-sourced0PASS
AX-2025-018845SS-31 (Elamipretide)FGPFGP-2501-F8605Janoshik2025-Q299.914.00—Buyer-sourced0PASS
AX-2025-020986ARA-290WXTWXT-2502-N3730Janoshik2025-Q299.933.35—Supplier-supplied1MARGINAL
AX-2025-020862MK-677 (Ibutamoren mesylate)CPCCPC-2503-G2382Medutest2025-Q298.565.3793.9Buyer-sourced1FAIL
AX-2025-019989N-Acetyl Semax AmideSWBSWB-2505-U7612Janoshik2025-Q299.468.1991.2Buyer-sourced0PASS
AX-2025-019817SemaglutideHomopeptideHOMO-2501-A5192Janoshik2025-Q299.765.25107.0Buyer-sourced0PASS
AX-2025-019514GHRP-6JEEPJEEP-2503-B8635Janoshik2025-Q299.414.50—Buyer-sourced0PASS
AX-2025-019513GHRP-6JEEPJEEP-2503-B8635Kestrel2025-Q299.214.7594.6Buyer-sourced0PASS
AX-2025-0195045-Amino-1MQJEEPJEEP-2412-M9286Janoshik2025-Q299.846.11—Buyer-sourced0FAIL
AX-2025-019427L-Glutathione (reduced)HYBHYB-2502-S7614Janoshik2025-Q299.378.5695.7Buyer-sourced0PASS
AX-2025-018804ExenatideFGPFGP-2504-V8032Janoshik2025-Q298.403.8198.7Buyer-sourced0PASS
AX-2025-021196RetatrutidePPGPPG-2501-B7212Janoshik2025-Q299.034.44—Supplier-supplied0PASS
AX-2025-020400TirzepatideMKMMKM-2411-B3993Medutest2025-Q297.494.6399.7Buyer-sourced1FAIL
AX-2025-020014N-Acetyl Semax AmideSWBSWB-2504-W7050VendorInvestigate2025-Q299.198.77—Buyer-sourced0PASS
AX-2025-019884MK-677 (Ibutamoren mesylate)HJHJ-2501-G5680Janoshik2025-Q299.675.44103.4Buyer-sourced0FAIL
AX-2025-019336EpitalonAMBAMB-2411-X6617Janoshik2025-Q299.935.87—Buyer-sourced1FAIL
AX-2025-019181BPC-157SinoPepSNP-2501-E3910Janoshik2025-Q299.573.5396.5Buyer-sourced0PASS
AX-2025-018909CJC-1295 with DACTFSTFS-{CAT}-1220Medutest2025-Q298.363.93—Buyer-sourced1MARGINAL
AX-2025-020851IpamorelinCPCCPC-2502-D1911PeptideMeter2025-Q299.214.93—Buyer-sourced2FAIL
AX-2025-020774AdipotideCPCCPC-2502-C9355VendorInvestigate2025-Q297.505.68—Buyer-sourced0PASS
AX-2025-020740TriptorelinSGNSGN-2504-A9334Janoshik2025-Q298.754.93—Buyer-sourced0PASS